Genetics of Angelman syndrome.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Human Genetics

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/302473PMID 10364509PMCID PMC1378067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angelman's syndrome: a neuropathological study

  2004cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• The ubiquitin system

  2000cited by this paper
• The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily

  1999cited by this paper
• Molecular mechanism of angelman syndrome in two large families involves an imprinting mutation.

  1999cited by this paper
• The spectrum of mutations in UBE3A causing Angelman syndrome.

  1999cited by this paper
• A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

  1999cited by this paper
• A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.

  1999cited by this paper
• Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.

  1999cited by this paper
• The ancestral gene for transcribed, low-copy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities.

  1999cited by this paper
• Effects of altered gene order or orientation of the locus control region on human β-globin gene expression in mice

  1999cited by this paper
• Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis.

  1998cited by this paper
• Mutation analysis of UBE3A in Angelman syndrome patients.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Mice Lacking the β3 Subunit of the GABAA Receptor Have the Epilepsy Phenotype and Many of the Behavioral Characteristics of Angelman Syndrome

  1998cited by this paper
• The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice

  1998cited by this paper
• Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

  1998cited by this paper
• An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript

  1998cited by this paper
• Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense.

  1998cited by this paper
• Ubiquitin, cellular inclusions and their role in neurodegeneration.

  1998cited by this paper
• Imprinting in Prader-Willi and Angelman syndromes.

  1998cited by this paper
• Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1

  1998cited by this paper
• A million dollar question: does LTP = memory?

  1998cited by this paper
• Imprinting in Angelman and Prader-Willi syndromes.

  1998cited by this paper
• Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

  1997cited by this paper
• Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain

  1997cited by this paper
• The Angelman syndrome candidate gene, UBE3AIE6-AP, is imprinted in brain

  1997cited by this paper
• A candidate model for angelman syndrome in the mouse

  1997cited by this paper
• Parental imprinting and human disease.

  1996cited by this paper
• Provirus integration into a gene encoding a ubiquitin-conjugating enzyme results in a placental defect and embryonic lethality.

  1996cited by this paper
• Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus.

  1995cited by this paper
• Angelman syndrome.

  1995cited by this paper
• Promoter-specific imprinting of the human insulin-like growth factor-II gene

  1994cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

  1991cited by this paper
• Puppet‐like syndrome of Angelman

  1991cited by this paper

• Brain-wide Genome Editing via STEP-RNPs for Treatment of Angelman Syndrome

  2025cites this paper
• Forestwalk: A Machine Learning Workflow Brings New Insights Into Posture and Balance in Rodent Beam Walking

  2024cites this paper
• A clinical-translational review of sleep problems in neurodevelopmental disabilities

  2024cites this paper
• The Effect of Oromotor and Sensory Treatment on Persistent Thumb Sucking and Basic Feeding and Swallowing in a Toddler with Angelman Syndrome: A Case Report

  2024cites this paper
• Establishing a Standardized DNA Extraction Method Using NaCl from Oral Mucosa Cells for Its Application in Imprinting Diseases Such as Prader–Willi and Angelman Syndromes: A Preliminary Investigation

  2024cites this paper
• Advances and Applications of Brain Organoids

  2023influential citation
• Angelman and Prader-Willi Syndromes: Sister Imprinting Disorders With High Complication Rates Following Spinal Deformity Surgery.

  2023cites this paper
• A review on Angelman syndrome

  2023cites this paper
• Identification of novel variations of oculocutaneous albinism type 2 with Prader–Willi syndrome/Angelman syndrome in two Chinese families

  2023cites this paper
• Novel epigenetic molecular therapies for imprinting disorders

  2023cites this paper
• Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A

  2022cites this paper
• Concurrent Reduced Expression of Contiguous PKD1, TSC2 and NTHL1 Leading to Kidney Diseases and Multiple Diverse Renal Cancers

  2022cites this paper
• An Analysis of Phenotype and Genotype in a Large Cohort of Chinese Children with Angelman Syndrome

  2022cites this paper
• Aberrant aggressive behavior in a mouse model of Angelman syndrome

  2021cites this paper
• A Comprehensive Approach to Rehabilitation Interventions in Patients with Angelman Syndrome: A Systematic Review of the Literature

  2021cites this paper
• Aberrant aggressive behavior in a mouse model of Angelman syndrome

  2021influential citation
• Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome

  2021cites this paper
• Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion

  2020cites this paper
• Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution

  2020cites this paper
• Evaluation of a TrkB agonist on spatial and motor learning in the Ube3a mouse model of Angelman syndrome

  2020cites this paper
• Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

  2020cites this paper
• Antisense oligonucleotide drugs for neurological and neuromuscular disease

  2020cites this paper
• Golgi pH and Ion Homeostasis in Health and Disease.

  2020cites this paper
• 7 Hessian Fly

  2019cites this paper
• Behavioral Evaluation of Angelman Syndrome Mice at Older Ages.

  2019cites this paper
• DigitalCommons@University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Hessian Fly Hessian Fly

  2019cites this paper
• Using Behavioral Approaches to Assess Memory, Imitation and Motor Performance in Children with Angelman Syndrome: Results of a Pilot Study

  2019cites this paper
• Spaced training improves learning in Ts65Dn and Ube3a mouse models of intellectual disabilities

  2019cites this paper
• Clinical, molecular genetics and therapeutic aspects of syndromic obesity

  2019influential citation
• Circadian biology and sleep in monogenic neurological disorders and its potential application in drug discovery.

  2019cites this paper
• Anesthesia considerations for an adult patient with Angelman syndrome.

  2018cites this paper
• Quantitative Measurement of Communication Ability in Children with Angelman Syndrome

  2018cites this paper
• The role of post translational modification in regulating Human Papillomavirus (HPV) E6 functions

  2018cites this paper
• Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.

  2018cites this paper
• The other side of the coin: Hypersociability

  2018cites this paper
• Prevalence of gastrointestinal symptoms in Angelman syndrome

  2017cites this paper
• Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells

  2017cites this paper
• Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2‐q13.3 duplication syndrome

  2017cites this paper
• Exotropia associated with syndromes

  2017cites this paper
• UbFluor: A Fluorescent Thioester to Monitor HECT E3 Ligase Catalysis

  2017cites this paper
• 35 – Chromosomes and Chromosomal Abnormalities

  2017cites this paper
• Towards targeted therapy for Angelman syndrome

  2016cites this paper
• Angelman syndrome: A review highlighting musculoskeletal and anatomical aberrations

  2016cites this paper
• Estudio de variantes estructurales del genoma humano asociadas a trastornos del neurodesarrollo

  2016cites this paper
• Psychomotor delay, dysmorphsim and epilepsy with underlying genetic etiology: A case report of first child with a genetically confirmed diagnosis of Angelman Syndrome on a hospital-based setting in Iraq

  2016cites this paper
• Angelman Syndrome Caused by Chromosomal Rearrangements: A Case Report of 46,XX,+der(13)t(13;15)(q14.1;q12)mat,-15 with an Atypical Phenotype and Review of the Literature

  2016cites this paper
• Molecular classes in 209 patients with Prader–Willi or Angelman syndromes: Lessons for genetic counseling

  2015cites this paper
• Uncovering a Role for SK2 in Angelman Syndrome.

  2015cites this paper
• Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome

  2015cites this paper
• Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B).

  2015cites this paper
• Angelman Syndrome due to familial translocation: unexpected additional results characterized by Microarray-based Comparative Genomic Hybridization

  2015cites this paper
• Minocycline Treatment and the Necessity to Develop a Novel Outcome Measure for Children with Angelman Syndrome

  2015cites this paper
• Insights into Common Microdeletion Syndromes

  2014cites this paper
• Proteomics analysis of an UBE3A knockout mouse modelling Angelman syndrome

  2014influential citation
• Genomic copy number variation in schizophrenia

  2014cites this paper
• Neurologic manifestations of Angelman syndrome.

  2013cites this paper
• Deletions and Other Structural Abnormalities of the Autosomes

  2013cites this paper
• The Active Form of E6AP/UBE3A Ubiquitin Ligase Is An Oligomer

  2013cites this paper
• Epigenetic Therapies in Neurological Diseases

  2013cites this paper
• The Active Form of E 6 AP / UBE 3 A Ubiquitin Ligase is an Oligomer

  2013cites this paper
• The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer*

  2013cites this paper
• Communication modality sampling for a toddler with Angelman syndrome.

  2013cites this paper
• Genomic Imprinting and Uniparental Disomy

  2013cites this paper
• Algorithmic Approach for Methyl-CpG Binding Protein 2 (MECP2) Gene Testing in Patients With Neurodevelopmental Disabilities

  2012cites this paper
• Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.

  2012cites this paper
• Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility

  2012cites this paper
• Phenotypic overlap in the contribution of individual genes to CNV pathogenicity revealed by cross-species computational analysis of single-gene mutations in humans, mice and zebrafish

  2012cites this paper
• Methylation-Specific Multiplex Ligation-Dependent Probe Amplification and Identification of Deletion Genetic Subtypes in Prader-Willi Syndrome

  2012cites this paper
• Angelman Syndrome: Proteomics Analysis of an UBE3A Knockout Mouse and Its Implications

  2012cites this paper
• Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a.

  2012cites this paper
• Efficacy of Increased Ube3a Protein Levels in the Brain in Rescuing the Phenotype of an Angelman Syndrome Mouse

  2012cites this paper
• Advanced Topics in Neurological Disorders

  2012cites this paper
• Ube 3 a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube 3 a

  2012cites this paper
• Developmental Delays Clinical Genetic Evaluation of the Child With Mental Retardation or

  2012cites this paper
• Neurodevelopmental outcomes in children with Angelman syndrome after 1 year of behavioural intervention

  2012cites this paper
• El estudio cromosómico y la técnica de hibridación in situ con fluorescencia (FISH) en el diagnóstico de sindromes de microdeleción

  2012cites this paper
• Synaptic Plasticity in Mouse Models of Autism Spectrum Disorders

  2012cites this paper
• Dysfunction of the Ubiquitin Ligase Ube3a May Be Associated with Synaptic Pathophysiology in a Mouse Model of Huntington Disease*

  2012cites this paper
• Ophthalmic findings in Angelman syndrome.

  2011cites this paper
• THE VELOCARDIOFACIAL SYNDROME THE PRADER-WILLI SYNDROME AND THE ANGELMAN SYNDROME NEUROFIBROMATOSIS THE WILLIAMS SYNDROME

  2011cites this paper
• Microdeletions and molecular genetics

  2011cites this paper
• A therapeutic trial of pro‐methylation dietary supplements in Angelman syndrome

  2011cites this paper
• Assessing Joint Attention Responding and Initiation in Children with Angelman Syndrome

  2011cites this paper
• Molecular and Clinical Aspects of Angelman Syndrome

  2011cites this paper
• The expression and assessment of emotions and internal states in individuals with severe or profound intellectual disabilities.

  2011cites this paper
• Novel deletion encompassing exons 5-12 of the UBE3A gene in a girl with Angelman syndrome.

  2011cites this paper
• Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism.

  2011cites this paper
• Age related change in social behavior in children with Angelman syndrome

  2011cites this paper
• Ubiquitination in Rho signaling.

  2011cites this paper
• Effects of adult familiarity on social behaviours in Angelman syndrome.

  2011cites this paper
• Alterations in white matter pathways in Angelman syndrome

  2011cites this paper
• Diseases frequently associated with epileptic seizures

  2010cites this paper
• Novel deletion of the E3A ubiquitin protein ligase gene detected by multiplex ligation-dependent probe amplification in a patient with Angelman syndrome

  2010cites this paper
• Double‐blind therapeutic trial in Angelman syndrome using betaine and folic acid

  2010cites this paper
• A novel UBE3A truncating mutation in large Tunisian Angelman syndrome pedigree

  2010cites this paper
• Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3

  2010cites this paper
• Clinical and genetic aspects of Angelman syndrome

  2010cites this paper
• The behavioral phenotype of the Angelman syndrome

  2010cites this paper
• Facts About Angelman Syndrome 7

  2010cites this paper
• Autism spectrum disorders and epigenetics.

  2010cites this paper